Close Menu

NEW YORK (GenomeWeb) – OpGen announced today that it has received notification from the Nasdaq that it has regained compliance with the market's applicable listing standards, and that its stock will continue to be listed and traded on the exchange.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.